Is Biktarvy covered by insurance?

Official answer

by Drugs.com

Most commercial and government health insurance plans in the U.S. cover some portion of the cost for Biktarvy. Typically a person taking Biktarvy pays between $0 and $9 per month.

Your cost will depend on your insurance plan, formulary, the state you live in, and any deductibles or copays you may have. You may be able to access financial assistance through the manufacturer of this drug.

Biktarvy (bictegravir, emtricitabine, and tenofovir), manufactured by Gilead Sciences, is used for HIV treatment as a once-daily, oral complete regimen.

  • Commercial insurance: If you have commercial or employer-sponsored coverage, your monthly cost will typically range between $0 and $5 per month. Call your insurance carrier to determine if Biktarvy is covered on your plan.
  • Medicare: Medicare, a government medical insurance plan for people 65 years and older in the U.S., will help you pay for the cost of Biktarvy. Typically a person with Medicare pays between $0 and $5 per month.
  • Medicaid: Medicaid also pays for Biktarvy. Medicaid is a U.S. government-run health insurance program that provides medical assistance for low-income individuals and families. Typically a person taking Biktarvy pays between $4 and $9 per month.

    • Gilead Sciences also offers the Gilead Advancing Access financial support program to help you afford your medicine. They may be able to assist you if you are insured, underinsured, or have no insurance. If eligible, Advancing Access may be able to help you lower your copay to as little as $0.

    Gilead also offers support to you and your physician if your Biktarvy prescription coverage is denied by your insurance plan.

    Patients enrolled in Medicare Part D and Medicaid, including patients in the Medicare Part D "donut hole”, are not eligible for the Gilead copay coupon.

    For more information, contact Gilead Sciences at:

  • GileadAdvancingAccess.com, or
  • call ‍‍1-800-226-2056 M–F, 9am–8pm ET

    • This is not all the information you need to know about Biktarvy (bictegravir, emtricitabine and tenofovir alafenamide) for safe and effective use and does not take the place of talking to your doctor about your treatment. Review the full Biktarvy information here, and discuss this information and any questions you have with your doctor or other health care provider.

    Related medical questions

    Disclaimer

    Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

    The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

    Popular Keywords